-
1
-
-
77950471425
-
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: A 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion
-
Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA. 2010. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J. Clin. Microbiol. 48: 1366-1377.
-
(2010)
J. Clin. Microbiol.
, vol.48
, pp. 1366-1377
-
-
Pfaller, M.A.1
Diekema, D.J.2
Gibbs, D.L.3
Newell, V.A.4
Ellis, D.5
Tullio, V.6
Rodloff, A.7
Fu, W.8
Ling, T.A.9
-
3
-
-
79958066469
-
Candida bloodstream infections: Comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)
-
Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. 2011. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int. J. Antimicrob. Agents 38:65-69.
-
(2011)
Int. J. Antimicrob. Agents
, vol.38
, pp. 65-69
-
-
Pfaller, M.A.1
Messer, S.A.2
Moet, G.J.3
Jones, R.N.4
Castanheira, M.5
-
4
-
-
84859613323
-
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
-
on behalf of the FUNGEMYCA Study Group
-
Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez del Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-Garcia-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G, on behalf of the FUNGEMYCA Study Group. 2012. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J. Antimicrob. Chemother. 67:1181-1187.
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, pp. 1181-1187
-
-
Pemán, J.1
Cantón, E.2
Quindós, G.3
Eraso, E.4
Alcoba, J.5
Guinea, J.6
Merino, P.7
Ruiz-Pérez-De-Pipaon, M.T.8
Del Molino Pérez, L.9
Linares-Sicilia, M.J.10
Marco, F.11
García, J.12
Roselló, E.M.13
Gómez-Garcia-De-La-Pedrosa, E.14
Borrell, N.15
Porras, A.16
Yagüe, G.17
-
5
-
-
66849127708
-
Recent experience with fungaemia: Change in species distribution and azole resistance
-
Chakrabarti A, Chatterjee SS, Rao KL, Zameer MM, Shivaprakash MR, Singhi S, Singh R, Varma SC. 2009. Recent experience with fungaemia: change in species distribution and azole resistance. Scand. J. Infect. Dis. 41:275-284.
-
(2009)
Scand. J. Infect. Dis.
, vol.41
, pp. 275-284
-
-
Chakrabarti, A.1
Chatterjee, S.S.2
Rao, K.L.3
Zameer, M.M.4
Shivaprakash, M.R.5
Singhi, S.6
Singh, R.7
Varma, S.C.8
-
6
-
-
80052619814
-
Species distribution and anti-fungal susceptibility of candidaemia at a multi super-speciality center in Southern India
-
Adhikary R, Joshi S. 2011. Species distribution and anti-fungal susceptibility of candidaemia at a multi super-speciality center in Southern India. Indian J. Med. Microbiol. 29:309-311.
-
(2011)
Indian J. Med. Microbiol.
, vol.29
, pp. 309-311
-
-
Adhikary, R.1
Joshi, S.2
-
7
-
-
77955295116
-
Candida tropicalis: Its prevalence, pathogenicity and increasing resistance to fluconazole
-
Kothavade RJ, Kura MM, Valand AG, Panthaki MH. 2010. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J. Med. Microbiol. 59:873-880.
-
(2010)
J. Med. Microbiol.
, vol.59
, pp. 873-880
-
-
Kothavade, R.J.1
Kura, M.M.2
Valand, A.G.3
Panthaki, M.H.4
-
8
-
-
33747165092
-
Epidemiology of candidemia in Brazil: A nationwide sentinel surveillance of candidemia in eleven medical centers
-
Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, Warnock D, Morgan J. 2006. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol. 44:2816-2823.
-
(2006)
J. Clin. Microbiol.
, vol.44
, pp. 2816-2823
-
-
Colombo, A.L.1
Nucci, M.2
Park, B.J.3
Nouér, S.A.4
Arthington-Skaggs, B.5
Da Matta, D.A.6
Warnock, D.7
Morgan, J.8
-
9
-
-
0035889586
-
Risk factors for Candida tropicalis fungemia in patients with cancer
-
Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP, Raad II. 2001. Risk factors for Candida tropicalis fungemia in patients with cancer. Clin. Infect. Dis. 33:1676-1681.
-
(2001)
Clin. Infect. Dis.
, vol.33
, pp. 1676-1681
-
-
Kontoyiannis, D.P.1
Vaziri, I.2
Hanna, H.A.3
Boktour, M.4
Thornby, J.5
Hachem, R.6
Bodey, G.P.7
Raad, I.I.8
-
11
-
-
60549098868
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
-
Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
-
(2009)
Clin. Infect. Dis.
, vol.48
, pp. 503-535
-
-
Pappas, P.G.1
Kauffman, C.A.2
Andes, D.3
Benjamin Jr., D.K.4
Calandra, T.F.5
Edwards Jr., J.E.6
Filler, S.G.7
Fisher, J.F.8
Kullberg, B.J.9
Ostrosky-Zeichner, L.10
Reboli, A.C.11
Rex, J.H.12
Walsh, T.J.13
Sobel, J.D.14
-
12
-
-
84867691299
-
ESCMID guideline for the diagnosis and management of Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases
-
ESCMID Fungal Infection Study Group
-
Ullmann AJ, Cornely OA, Donnelly JP, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Cuenca-Estrella M, ESCMID Fungal Infection Study Group. 2012. ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin. Microbiol. Infect. 18(Suppl 7):1-8.
-
(2012)
Clin. Microbiol. Infect.
, vol.18
, Issue.SUPPL. 7
, pp. 1-8
-
-
Ullmann, A.J.1
Cornely, O.A.2
Donnelly, J.P.3
Akova, M.4
Arendrup, M.C.5
Arikan-Akdagli, S.6
Bassetti, M.7
Bille, J.8
Calandra, T.9
Castagnola, E.10
Garbino, J.11
Groll, A.H.12
Herbrecht, R.13
Hope, W.W.14
Jensen, H.E.15
Kullberg, B.J.16
Lass-Flörl, C.17
Lortholary, O.18
Meersseman, W.19
Petrikkos, G.20
Richardson, M.D.21
Roilides, E.22
Verweij, P.E.23
Viscoli, C.24
Cuenca-Estrella, M.25
more..
-
13
-
-
2942718513
-
Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies
-
Myoken Y, Kyo T, Fujihara M, Sugata T, Mikami Y. 2004. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies. Haematologica 89: 378-380.
-
(2004)
Haematologica
, vol.89
, pp. 378-380
-
-
Myoken, Y.1
Kyo, T.2
Fujihara, M.3
Sugata, T.4
Mikami, Y.5
-
14
-
-
27644564701
-
Mechanisms of azole resistance in a clinical isolate of Candida tropicalis
-
Vandeputte P, Larcher G, Bergés T, Renier G, Chabasse D, Bouchara JP. 2005. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob. Agents Chemother. 49:4608-4615.
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 4608-4615
-
-
Vandeputte, P.1
Larcher, G.2
Bergés, T.3
Renier, G.4
Chabasse, D.5
Bouchara, J.P.6
-
15
-
-
43749123271
-
Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006
-
Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ; TSARY Hospitals. 2008. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Diagn. Microbiol. Infect. Dis. 61:175-180.
-
(2008)
Diagn. Microbiol. Infect. Dis.
, vol.61
, pp. 175-180
-
-
Yang, Y.L.1
Wang, A.H.2
Wang, C.W.3
Cheng, W.T.4
Li, S.Y.5
Lo, H.J.6
Hospitals, T.7
-
16
-
-
0028969417
-
Detection of amphotericin B-resistant Candida isolates in a broth-based system
-
Rex JH, Cooper CR, Merz WG, Jr, Galgiani JN, Anaissie EJ. 1995. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob. Agents Chemother. 39:906-909.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 906-909
-
-
Rex, J.H.1
Cooper, C.R.2
Merz Jr., W.G.3
Galgiani, J.N.4
Anaissie, E.J.5
-
17
-
-
3042577890
-
Patterns of amphotericin B killing kinetics against seven Candida species
-
Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A. 2004. Patterns of amphotericin B killing kinetics against seven Candida species. Antimicrob. Agents Chemother. 48:2477-2482.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 2477-2482
-
-
Cantón, E.1
Pemán, J.2
Gobernado, M.3
Viudes, A.4
Espinel-Ingroff, A.5
-
18
-
-
0036156041
-
Molecular basis of resistance to azole antifungals
-
Lupetti A, Danesi R, Campa M, Del Tacca M, Kelly S. 2002. Molecular basis of resistance to azole antifungals. Trends Mol. Med. 8:76-81.
-
(2002)
Trends Mol. Med.
, vol.8
, pp. 76-81
-
-
Lupetti, A.1
Danesi, R.2
Campa, M.3
Del Tacca, M.4
Kelly, S.5
-
19
-
-
0036488166
-
Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences
-
Sanglard D, Odds FC. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
-
(2002)
Lancet Infect. Dis.
, vol.2
, pp. 73-85
-
-
Sanglard, D.1
Odds, F.C.2
-
20
-
-
84055199809
-
Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment
-
Pfaller MA. 2012. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 125:S3-S13.
-
(2012)
Am. J. Med.
, vol.125
-
-
Pfaller, M.A.1
-
21
-
-
0034812585
-
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients
-
Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2676-2684.
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 2676-2684
-
-
Perea, S.1
López-Ribot, J.L.2
Kirkpatrick, W.R.3
McAtee, R.K.4
Santillán, R.A.5
Martínez, M.6
Calabrese, D.7
Sanglard, D.8
Patterson, T.F.9
-
22
-
-
77749291956
-
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azolesusceptible and azole-resistant clinical isolates: New substitutions and a review of the literature
-
Morio F, Loge C, Besse B, Hennequin C, Le Pape P. 2010. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azolesusceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn. Microbiol. Infect. Dis. 66:373-384.
-
(2010)
Diagn. Microbiol. Infect. Dis.
, vol.66
, pp. 373-384
-
-
Morio, F.1
Loge, C.2
Besse, B.3
Hennequin, C.4
Le Pape, P.5
-
23
-
-
0032733078
-
Y132H substitution in Candida albicans sterol 14-demethylase confers fluconazole resistance by preventing binding to haem
-
Kelly SL, Lamb DC, Kelly DE. 1999. Y132H substitution in Candida albicans sterol 14-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol. Lett. 180:171-175.
-
(1999)
FEMS Microbiol. Lett.
, vol.180
, pp. 171-175
-
-
Kelly, S.L.1
Lamb, D.C.2
Kelly, D.E.3
-
24
-
-
0031938057
-
Amino acid substitutions in the cytochrome P-450 lanosterol 14-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents
-
Sanglard D, Ischer F, Koymans L, Bille J. 1998. Amino acid substitutions in the cytochrome P-450 lanosterol 14-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42:241-253.
-
(1998)
Antimicrob. Agents Chemother.
, vol.42
, pp. 241-253
-
-
Sanglard, D.1
Ischer, F.2
Koymans, L.3
Bille, J.4
-
25
-
-
84864577072
-
Fungal cytochrome P450 sterol 14-demethylase (CYP51) and azole resistance in plant and human pathogens
-
Becher R, Wirsel SG. 2012. Fungal cytochrome P450 sterol 14-demethylase (CYP51) and azole resistance in plant and human pathogens. Appl. Microbiol. Biotechnol. 95:825-840.
-
(2012)
Appl. Microbiol. Biotechnol.
, vol.95
, pp. 825-840
-
-
Becher, R.1
Wirsel, S.G.2
-
26
-
-
0346784897
-
Three-dimensional models of wild-type and mutated forms of cytochrome P450 14-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding
-
Xiao L, Madison V, Chau AS, Loebenberg D, Palermo RE, McNicholas PM. 2004. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob. Agents Chemother. 48:568-574.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 568-574
-
-
Xiao, L.1
Madison, V.2
Chau, A.S.3
Loebenberg, D.4
Palermo, R.E.5
McNicholas, P.M.6
-
27
-
-
84875276783
-
Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China
-
Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, Peng Y. 2013. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J. Antimicrob. Chemother. 68:778-785.
-
(2013)
J. Antimicrob. Chemother.
, vol.68
, pp. 778-785
-
-
Jiang, C.1
Dong, D.2
Yu, B.3
Cai, G.4
Wang, X.5
Ji, Y.6
Peng, Y.7
-
28
-
-
0034075720
-
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750
-
Barchiesi F, Calabrese D, Sanglard D, Falcone Di Francesco L, Caselli F, Giannini D, Giacometti A, Gavaudan S, Scalise G. 2000. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob. Agents Chemother. 44:1578-1584.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 1578-1584
-
-
Barchiesi, F.1
Calabrese, D.2
Sanglard, D.3
Falcone Di Francesco, L.4
Caselli, F.5
Giannini, D.6
Giacometti, A.7
Gavaudan, S.8
Scalise, G.9
-
29
-
-
77950180902
-
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection
-
MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D. 2010. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrob. Agents Chemother. 54:1476-1483.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 1476-1483
-
-
Maccallum, D.M.1
Coste, A.2
Ischer, F.3
Jacobsen, M.D.4
Odds, F.C.5
Sanglard, D.6
-
30
-
-
31944440019
-
Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance
-
Miyazaki T, Miyazaki Y, Izumikawa K, Kakeya H, Miyakoshi S, Bennett JE, Kohno S. 2006. Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance. Antimicrob. Agents Chemother. 50:580-586.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 580-586
-
-
Miyazaki, T.1
Miyazaki, Y.2
Izumikawa, K.3
Kakeya, H.4
Miyakoshi, S.5
Bennett, J.E.6
Kohno, S.7
-
31
-
-
84860906111
-
Selecting an invertebrate model host for the study of fungal pathogenesis
-
doi:10.1371/journal.ppat.1002451
-
Desalermos A, Fuchs BB, Mylonakis E. 2012. Selecting an invertebrate model host for the study of fungal pathogenesis. PLoS Pathog. 8:e1002451. doi:10.1371/journal.ppat.1002451.
-
(2012)
PLoS Pathog.
, vol.8
-
-
Desalermos, A.1
Fuchs, B.B.2
Mylonakis, E.3
-
32
-
-
79960442678
-
Wax moth larva (Galleria mellonella): An in vivo model for assessing the efficacy of antistaphylococcal agents
-
Desbois AP, Coote PJ. 2011. Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents. J. Antimicrob. Chemother. 66:1785-1790.
-
(2011)
J. Antimicrob. Chemother.
, vol.66
, pp. 1785-1790
-
-
Desbois, A.P.1
Coote, P.J.2
-
33
-
-
84864811129
-
Legionella pneumophila pathogenesis in the Galleria mellonella infection model
-
Harding CR, Schroeder GN, Reynolds S, Kosta A, Collins JW, Mousnier A, Frankel G. 2012. Legionella pneumophila pathogenesis in the Galleria mellonella infection model. Infect. Immun. 80:2780-2790.
-
(2012)
Infect. Immun.
, vol.80
, pp. 2780-2790
-
-
Harding, C.R.1
Schroeder, G.N.2
Reynolds, S.3
Kosta, A.4
Collins, J.W.5
Mousnier, A.6
Frankel, G.7
-
34
-
-
21544465310
-
Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis
-
Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A. 2005. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect. Immun. 73:3842-3850.
-
(2005)
Infect. Immun.
, vol.73
, pp. 3842-3850
-
-
Mylonakis, E.1
Moreno, R.2
El Khoury, J.B.3
Idnurm, A.4
Heitman, J.5
Calderwood, S.B.6
Ausubel, F.M.7
Diener, A.8
-
35
-
-
81955164780
-
Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host
-
Coleman JJ, Muhammed M, Kasperkovitz PV, Vyas JM, Mylonakis E. 2011. Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host. Fungal Biol. 115:1279-1289.
-
(2011)
Fungal Biol.
, vol.115
, pp. 1279-1289
-
-
Coleman, J.J.1
Muhammed, M.2
Kasperkovitz, P.V.3
Vyas, J.M.4
Mylonakis, E.5
-
36
-
-
79951500577
-
Pathogenicity of Aspergillus fumigatus mutants assessed in Galleria mellonella matches that in mice
-
Slater JL, Gregson L, Denning DW, Warn PA. 2011. Pathogenicity of Aspergillus fumigatus mutants assessed in Galleria mellonella matches that in mice. Med. Mycol. 49:S107-S113.
-
(2011)
Med. Mycol.
, vol.49
-
-
Slater, J.L.1
Gregson, L.2
Denning, D.W.3
Warn, P.A.4
-
37
-
-
84879926068
-
The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast
-
Mesa-Arango AC, Forastiero A, Bernal-Martínez L, Cuenca-Estrella M, Mellado E, Zaragoza O. 2013. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med. Mycol. 51:461-472.
-
(2013)
Med. Mycol.
, vol.51
, pp. 461-472
-
-
Mesa-Arango, A.C.1
Forastiero, A.2
Bernal-Martínez, L.3
Cuenca-Estrella, M.4
Mellado, E.5
Zaragoza, O.6
-
38
-
-
84875543551
-
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the in vitro susceptibility profile
-
doi:10.1371/journal.pone.0060047
-
Scorzoni L, de Lucas MP, Mesa-Arango AC, Fusco-Almeida AM, Lozano E, Cuenca-Estrella M, Mendes-Giannini MJ, Zaragoza O. 2013. Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the in vitro susceptibility profile. PLoS One 8:e60047. doi:10.1371/journal.pone. 0060047.
-
(2013)
PLoS One
, vol.8
-
-
Scorzoni, L.1
De Lucas, M.P.2
Mesa-Arango, A.C.3
Fusco-Almeida, A.M.4
Lozano, E.5
Cuenca-Estrella, M.6
Mendes-Giannini, M.J.7
Zaragoza, O.8
-
39
-
-
84862606187
-
EUCAST technical note on the EUCAST definitive document EDef 7.2: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)
-
Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope W. EUCASTAFST. 2012. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin. Microbiol. Infect. 18:E246-E247.
-
(2012)
Clin. Microbiol. Infect.
, vol.18
-
-
Arendrup, M.C.1
Cuenca-Estrella, M.2
Lass-Flörl, C.3
Eucastafst, H.W.4
-
40
-
-
81255127375
-
EUCAST technical note on amphotericin B
-
European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing
-
Lass-Flörl C, Arendrup MC, Rodriguez-Tudela JL, Cuenca-Estrella M, Donnelly P, Hope W; European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing. 2011. EUCAST technical note on amphotericin B. Clin. Microbiol. Infect. 17:E27-E29.
-
(2011)
Clin. Microbiol. Infect.
, vol.17
-
-
Lass-Flörl, C.1
Arendrup, M.C.2
Rodriguez-Tudela, J.L.3
Cuenca-Estrella, M.4
Donnelly, P.5
Hope, W.6
-
41
-
-
80054077681
-
EUCAST technical note on anidulafungin
-
Arendrup MC, Rodriguez-Tudela JL, Lass Flörl C, Cuenca-Estrella M, Donnelly JP, Hope W. EUCAST-AFST. 2011. EUCAST technical note on anidulafungin. Clin. Microbiol. Infect. 17:E18-E20.
-
(2011)
Clin. Microbiol. Infect.
, vol.17
-
-
Arendrup, M.C.1
Rodriguez-Tudela, J.L.2
Lass Flörl, C.3
Cuenca-Estrella, M.4
Donnelly, J.P.5
Eucast-Afst, H.W.6
-
42
-
-
0043270593
-
Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents
-
Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J. 2003. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother. 47:2404-2412.
-
(2003)
Antimicrob. Agents Chemother.
, vol.47
, pp. 2404-2412
-
-
Sanglard, D.1
Ischer, F.2
Parkinson, T.3
Falconer, D.4
Bille, J.5
-
43
-
-
0031757669
-
Multiple sequence alignment with Clustal X
-
Jeanmougin F, Thompson JD, Gouy M, Higgins DG, Gibson TJ. 1998. Multiple sequence alignment with Clustal X. Trends Biochem. Sci. 23: 403-405.
-
(1998)
Trends Biochem. Sci.
, vol.23
, pp. 403-405
-
-
Jeanmougin, F.1
Thompson, J.D.2
Gouy, M.3
Higgins, D.G.4
Gibson, T.J.5
-
44
-
-
0035991849
-
Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates
-
for the Candidemia Active Surveillance Group
-
Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA, Harrison LH, Sofair AN, Warnock DW, for the Candidemia Active Surveillance Group. 2002. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob. Agents Chemother. 46:2477-2481.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 2477-2481
-
-
Arthington-Skaggs, B.A.1
Lee-Yang, W.2
Ciblak, M.A.3
Frade, J.P.4
Brandt, M.E.5
Hajjeh, R.A.6
Harrison, L.H.7
Sofair, A.N.8
Warnock, D.W.9
-
45
-
-
38649141163
-
Ergosterol biosynthesis pathway in Aspergillus fumigatus
-
Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez JF, Grimalt JO, Cuenca-Estrella JM, Rodriguez-Tudela JL. 2008. Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids 73:339-347.
-
(2008)
Steroids
, vol.73
, pp. 339-347
-
-
Alcazar-Fuoli, L.1
Mellado, E.2
Garcia-Effron, G.3
Lopez, J.F.4
Grimalt, J.O.5
Cuenca-Estrella, J.M.6
Rodriguez-Tudela, J.L.7
-
46
-
-
0035057290
-
Ergosterol biosynthesis in novel melanized fungi from hypersaline environments
-
Méjanelle L, Lòpez JF, Gunde-Cimerman N, Grimalt JO. 2001. Ergosterol biosynthesis in novel melanized fungi from hypersaline environments. J. Lipid Res. 42:352-358.
-
(2001)
J. Lipid Res.
, vol.42
, pp. 352-358
-
-
Méjanelle, L.1
Lòpez, J.F.2
Gunde-Cimerman, N.3
Grimalt, J.O.4
-
47
-
-
84857404369
-
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus
-
Yasmin S, Alcazar-Fuoli L, Gründlinger M, Puempel T, Cairns T, Blatzer M, Lopez JF, Grimalt JO, Bignell E, Haas H. 2012. Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus. Proc. Natl. Acad. Sci. U. S. A. 109:E497-E504.
-
(2012)
Proc. Natl. Acad. Sci. U. S. A.
, vol.109
-
-
Yasmin, S.1
Alcazar-Fuoli, L.2
Gründlinger, M.3
Puempel, T.4
Cairns, T.5
Blatzer, M.6
Lopez, J.F.7
Grimalt, J.O.8
Bignell, E.9
Haas, H.10
-
48
-
-
32144432437
-
The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling
-
Arnold K, Bordoli L, Kopp J, Schwede T. 2006. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195-201.
-
(2006)
Bioinformatics
, vol.22
, pp. 195-201
-
-
Arnold, K.1
Bordoli, L.2
Kopp, J.3
Schwede, T.4
-
49
-
-
58149193233
-
The SWISSMODEL Repository and associated resources
-
Kiefer F, Arnold K, Künzli M, Bordoli L, Schwede T. 2009. The SWISSMODEL Repository and associated resources. Nucleic Acids Res. 37: D387-D392.
-
(2009)
Nucleic Acids Res.
, vol.37
-
-
Kiefer, F.1
Arnold, K.2
Künzli, M.3
Bordoli, L.4
Schwede, T.5
-
50
-
-
0029004590
-
Protein modeling by E-mail
-
Peitsch MC. 1995. Protein modeling by E-mail. Bio/Technology 13:658-660.
-
(1995)
Bio/Technology
, vol.13
, pp. 658-660
-
-
Peitsch, M.C.1
-
51
-
-
77950023120
-
Structural basis of human CYP51 inhibition by antifungal azoles
-
Strushkevich N, Usanov SA, Park HW. 2010. Structural basis of human CYP51 inhibition by antifungal azoles. J. Mol. Biol. 397:1067-1078.
-
(2010)
J. Mol. Biol.
, vol.397
, pp. 1067-1078
-
-
Strushkevich, N.1
Usanov, S.A.2
Park, H.W.3
-
52
-
-
0032865613
-
Rhodamine 6G efflux for the detection of CDR1 overexpressing azoleresistant Candida albicans strains
-
Maesaki S, Marichal P, Vanden Bossche H, Sanglard D, Kohno S. 1999. Rhodamine 6G efflux for the detection of CDR1 overexpressing azoleresistant Candida albicans strains. J. Antimicrob. Chemother. 44:27-31.
-
(1999)
J. Antimicrob. Chemother.
, vol.44
, pp. 27-31
-
-
Maesaki, S.1
Marichal, P.2
Vanden Bossche, H.3
Sanglard, D.4
Kohno, S.5
-
53
-
-
0032540222
-
Assessing protein structures with a non-local atomic interaction energy
-
Melo F, Feytmans E. 1998. Assessing protein structures with a non-local atomic interaction energy. J. Mol. Biol. 277:1141-1152.
-
(1998)
J. Mol. Biol.
, vol.277
, pp. 1141-1152
-
-
Melo, F.1
Feytmans, E.2
-
54
-
-
84879018308
-
Molecular mechanisms of drug resistance in clinical Candida species isolated in Tunisian hospitals
-
Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, Manai M, Sanglard D. 2013. Molecular mechanisms of drug resistance in clinical Candida species isolated in Tunisian hospitals. Antimicrob. Agents Chemother. 57:3182-3193.
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 3182-3193
-
-
Eddouzi, J.1
Parker, J.E.2
Vale-Silva, L.A.3
Coste, A.4
Ischer, F.5
Kelly, S.6
Manai, M.7
Sanglard, D.8
-
55
-
-
0032826408
-
Contribution of mutations in the cytochrome P450 14-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans
-
Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W, Borgers M, Ramaekers FC, Odds FC, Bossche HV. 1999. Contribution of mutations in the cytochrome P450 14-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145:2701-2713.
-
(1999)
Microbiology
, vol.145
, pp. 2701-2713
-
-
Marichal, P.1
Koymans, L.2
Willemsens, S.3
Bellens, D.4
Verhasselt, P.5
Luyten, W.6
Borgers, M.7
Ramaekers, F.C.8
Odds, F.C.9
Bossche, H.V.10
-
56
-
-
84864389183
-
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B
-
Hull CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL. 2012. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B. Antimicrob. Agents Chemother. 56:4223-4232.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 4223-4232
-
-
Hull, C.M.1
Parker, J.E.2
Bader, O.3
Weig, M.4
Gross, U.5
Warrilow, A.G.6
Kelly, D.E.7
Kelly, S.L.8
-
57
-
-
0035853108
-
Crystal structure of cytochrome P450 14-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors
-
Podust LM, Poulos TL, Waterman MR. 2001. Crystal structure of cytochrome P450 14-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98:3068-3073.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 3068-3073
-
-
Podust, L.M.1
Poulos, T.L.2
Waterman, M.R.3
-
58
-
-
0023753791
-
A single amino acid substitution converts cytochrome P450(14DM) to an inactive form, cytochrome P450SG1: Complete primary structures deduced from cloned DNAS
-
Ishida N, Aoyama Y, Hatanaka R, Oyama Y, Imajo S, Ishiguro M, Oshima T, Nakazato H, Noguchi T, Maitra US, Mohan VP, Sprinson DB, Yoshida Y. 1988. A single amino acid substitution converts cytochrome P450(14DM) to an inactive form, cytochrome P450SG1: complete primary structures deduced from cloned DNAS. Biochem. Biophys. Res. Commun. 155:317-323.
-
(1988)
Biochem. Biophys. Res. Commun.
, vol.155
, pp. 317-323
-
-
Ishida, N.1
Aoyama, Y.2
Hatanaka, R.3
Oyama, Y.4
Imajo, S.5
Ishiguro, M.6
Oshima, T.7
Nakazato, H.8
Noguchi, T.9
Maitra, U.S.10
Mohan, V.P.11
Sprinson, D.B.12
Yoshida, Y.13
-
59
-
-
2542494102
-
Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles
-
Chau AS, Mendrick CA, Sabatelli FJ, Loebenberg D, McNicholas PM. 2004. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob. Agents Chemother. 48:2124-2131.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 2124-2131
-
-
Chau, A.S.1
Mendrick, C.A.2
Sabatelli, F.J.3
Loebenberg, D.4
McNicholas, P.M.5
-
60
-
-
84863164890
-
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/ posaconazole
-
Sionov E, Chang YC, Garraffo HM, Dolan MA, Ghannoum MA, Kwon-Chung KJ. 2012. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/ posaconazole. Antimicrob. Agents Chemother. 56:1162-1169.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 1162-1169
-
-
Sionov, E.1
Chang, Y.C.2
Garraffo, H.M.3
Dolan, M.A.4
Ghannoum, M.A.5
Kwon-Chung, K.J.6
-
61
-
-
0242290930
-
G484S amino acid substitution in lanosterol 14-demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate
-
Rodero L, Mellado E, Rodriguez AC, Salve A, Guelfand L, Cahn P, Cuenca-Estrella M, Davel G, Rodriguez-Tudela JL. 2003. G484S amino acid substitution in lanosterol 14-demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob. Agents Chemother. 47:3653-3656.
-
(2003)
Antimicrob. Agents Chemother.
, vol.47
, pp. 3653-3656
-
-
Rodero, L.1
Mellado, E.2
Rodriguez, A.C.3
Salve, A.4
Guelfand, L.5
Cahn, P.6
Cuenca-Estrella, M.7
Davel, G.8
Rodriguez-Tudela, J.L.9
-
62
-
-
84862726659
-
Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis
-
Pelaez T, Gijón P, Bunsow E, Bouza E, Sánchez-Yebra W, Valerio M, Gama B, Cuenca-Estrella M, Mellado E. 2012. Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis. J. Clin. Microbiol. 50:2531-2534.
-
(2012)
J. Clin. Microbiol.
, vol.50
, pp. 2531-2534
-
-
Pelaez, T.1
Gijón, P.2
Bunsow, E.3
Bouza, E.4
Sánchez-Yebra, W.5
Valerio, M.6
Gama, B.7
Cuenca-Estrella, M.8
Mellado, E.9
-
63
-
-
0033584392
-
The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity
-
Kelly SL, Lamb DC, Loeffler J, Einsele H, Kelly DE. 1999. The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity. Biochem. Biophys. Res. Commun. 262:174-179.
-
(1999)
Biochem. Biophys. Res. Commun.
, vol.262
, pp. 174-179
-
-
Kelly, S.L.1
Lamb, D.C.2
Loeffler, J.3
Einsele, H.4
Kelly, D.E.5
-
64
-
-
79954438596
-
Heterologous expression and characterization of the sterol 14α-demethylase CYP51F1 from Candida albicans
-
Park HG, Lee IS, Chun IJ, Yun CH, Johnston JB, Ortiz de Montellon PR, Kima D. 2011. Heterologous expression and characterization of the sterol 14α-demethylase CYP51F1 from Candida albicans. Arch. Biochem. Biophys. 509:9-15.
-
(2011)
Arch. Biochem. Biophys.
, vol.509
, pp. 9-15
-
-
Park, H.G.1
Lee, I.S.2
Chun, I.J.3
Yun, C.H.4
Johnston, J.B.5
Ortiz De Montellon, P.R.6
Kima, D.7
-
65
-
-
79959615872
-
Molecular modelling of the emergence of azole resistance in Mycosphaerella graminicola
-
doi:10.1371 /journal.pone.0020973
-
Mullins JGL, Parker JE, Cools HJ, Togawa RC, Lucas JA, Fraaije BA, Kelly DE, Kelly S. 2011. Molecular modelling of the emergence of azole resistance in Mycosphaerella graminicola. PLoS One 6:e20973. doi:10.1371 /journal.pone. 0020973.
-
(2011)
PLoS One
, vol.6
-
-
Jgl, M.1
Parker, J.E.2
Cools, H.J.3
Togawa, R.C.4
Lucas, J.A.5
Fraaije, B.A.6
Kelly, D.E.7
Kelly, S.8
-
66
-
-
0042544006
-
A mutation in the 14-demethylase gene of Uncinula necator that correlates with resistance to a sterol biosynthesis inhibitor
-
Délye C, Laigret F, Corio-Costet MF. 1997. A mutation in the 14-demethylase gene of Uncinula necator that correlates with resistance to a sterol biosynthesis inhibitor. Appl. Environ. Microbiol. 63:2966-2970.
-
(1997)
Appl. Environ. Microbiol.
, vol.63
, pp. 2966-2970
-
-
Délye, C.1
Laigret, F.2
Corio-Costet, M.F.3
-
67
-
-
69249221482
-
Analysis of the CYP51 gene and encoded protein in propiconazole-resistant isolates of Mycosphaerella fijiensis
-
Cañas-Gutiérrez GP, Angarita-Velásquez MJ, Restrepo-Flórez JM, Rodríguez P, Moreno CX, Arango R. 2009. Analysis of the CYP51 gene and encoded protein in propiconazole-resistant isolates of Mycosphaerella fijiensis. Pest. Manag. Sci. 65:892-899.
-
(2009)
Pest. Manag. Sci.
, vol.65
, pp. 892-899
-
-
Cañas-Gutiérrez, G.P.1
Angarita-Velásquez, M.J.2
Restrepo-Flórez, J.M.3
Rodríguez, P.4
Moreno, C.X.5
Arango, R.6
-
68
-
-
0032428659
-
PCR cloning and detection of point mutations in the eburicol 14-demethylase (CYP51) gene from Erysiphe graminis F. Sp. Hordei, a "recalcitrant" fungus
-
Délye C, Bousset L, Corio-Costet MF. 1998. PCR cloning and detection of point mutations in the eburicol 14-demethylase (CYP51) gene from Erysiphe graminis f. sp. hordei, a "recalcitrant" fungus. Curr. Genet. 34:399-403.
-
(1998)
Curr. Genet.
, vol.34
, pp. 399-403
-
-
Délye, C.1
Bousset, L.2
Corio-Costet, M.F.3
-
69
-
-
0028942449
-
Mode of action and resistance to azole antifungals associated with the formation of 14-methylergosta-8,24(28)-dien-3,6-diol
-
Kelly SL, Lamb DC, Corran AJ, Baldwin BC, Kelly DE. 1995. Mode of action and resistance to azole antifungals associated with the formation of 14-methylergosta-8,24(28)-dien-3,6-diol. Biochem. Biophys. Res. Commun. 207:910-915.
-
(1995)
Biochem. Biophys. Res. Commun.
, vol.207
, pp. 910-915
-
-
Kelly, S.L.1
Lamb, D.C.2
Corran, A.J.3
Baldwin, B.C.4
Kelly, D.E.5
-
70
-
-
0042268120
-
Molecular mechanisms of itraconazole resistance in Candida dubliniensis
-
Pinjon E, Moran GP, Jackson CJ, Kelly SL, Sanglard D, Coleman DC, Sullivan DJ. 2003. Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 47: 2424-2437.
-
(2003)
Antimicrob. Agents Chemother.
, vol.47
, pp. 2424-2437
-
-
Pinjon, E.1
Moran, G.P.2
Jackson, C.J.3
Kelly, S.L.4
Sanglard, D.5
Coleman, D.C.6
Sullivan, D.J.7
-
71
-
-
84865368550
-
Amino acid substitutions in the Candida albicans sterol δ5,6-desaturase (Erg3p) confer azole resistance: Characterization of two novel mutants with impaired virulence
-
Morio F, Pagniez F, Lacroix C, Miegeville M, Le Pape P. 2012. Amino acid substitutions in the Candida albicans sterol δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J. Antimicrob. Chemother. 67:2131-2138.
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, pp. 2131-2138
-
-
Morio, F.1
Pagniez, F.2
Lacroix, C.3
Miegeville, M.4
Le Pape, P.5
-
72
-
-
78049243452
-
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans
-
Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Rolley N, Kelly DE, Kelly SL. 2010. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans. Antimicrob. Agents Chemother. 54:4527-4533.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 4527-4533
-
-
Martel, C.M.1
Parker, J.E.2
Bader, O.3
Weig, M.4
Gross, U.5
Warrilow, A.G.6
Rolley, N.7
Kelly, D.E.8
Kelly, S.L.9
-
73
-
-
1242351240
-
Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens
-
Kavanagh K, Reeves EP. 2004. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol. Rev. 28:101-112.
-
(2004)
FEMS Microbiol. Rev.
, vol.28
, pp. 101-112
-
-
Kavanagh, K.1
Reeves, E.P.2
|